Details for New Drug Application (NDA): 074561
✉ Email this page to a colleague
The generic ingredient in LOCHOLEST is cholestyramine. There are eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 074561
Tradename: | LOCHOLEST |
Applicant: | Chartwell Rx |
Ingredient: | cholestyramine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 074561
Mechanism of Action | Bile-acid Binding Activity |
Suppliers and Packaging for NDA: 074561
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LOCHOLEST | cholestyramine | POWDER;ORAL | 074561 | ANDA | Chartwell RX, LLC | 62135-008 | 62135-008-56 | 378 g in 1 CAN (62135-008-56) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/PACKET | ||||
Approval Date: | Aug 15, 1996 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 4GM RESIN/SCOOPFUL | ||||
Approval Date: | Aug 15, 1996 | TE: | AB | RLD: | No |
Complete Access Available with Subscription